Selected research
Industry Research
Polynucleotides Injectable Industry Research Report 2026
Market perspective
The global Polynucleotides Injectable market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Polynucleotides Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Polynucleotides Injectable is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Polynucleotides Injectable is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Polynucleotides Injectable include PharmaResearch Products Co., Ltd., Mastelli Srl, Promoitalia Group S.p.A., GUNA S.p.A., Caregen Co., Ltd., Medytox Inc., Suneva Medical, Inc., Euroresearch S.r.l. and Anteis SA (now part of Merz Pharmaceuticals), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Polynucleotides Injectable market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polynucleotides Injectable Market by Company
PharmaResearch Products Co., Ltd.
Mastelli Srl
Promoitalia Group S.p.A.
GUNA S.p.A.
Caregen Co., Ltd.
Medytox Inc.
Suneva Medical, Inc.
Euroresearch S.r.l.
Anteis SA (now part of Merz Pharmaceuticals)
Hyundai Pharm Co., Ltd.
Regen Biotech, Inc.
Evolus, Inc.
Cleviel
Promedica International
NeoGenesis Co., Ltd.
Polynucleotides Injectable Segment by Type
Eyes
Lips
Forehead
Jawline & Cheekbones
Others
Polynucleotides Injectable Segment by Application
MedSpas
Aesthetic & Cosmetic Centers
Hospitals
Polynucleotides Injectable Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polynucleotides Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polynucleotides Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polynucleotides Injectable.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polynucleotides Injectable manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polynucleotides Injectable by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polynucleotides Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Eyes
- Lips
- Forehead
- Jawline & Cheekbones
- Others
Applications
- MedSpas
- Aesthetic & Cosmetic Centers
- Hospitals
Companies covered
- PharmaResearch Products Co., Ltd.
- Mastelli Srl
- Promoitalia Group S.p.A.
- GUNA S.p.A.
- Caregen Co., Ltd.
- Medytox Inc.
- Suneva Medical, Inc.
- Euroresearch S.r.l.
- Anteis SA (now part of Merz Pharmaceuticals)
- Hyundai Pharm Co., Ltd.
- Regen Biotech, Inc.
- Evolus, Inc.
- Cleviel
- Promedica International
- NeoGenesis Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Polynucleotides Injectable Market Size (2021-2032)
- 2.2.2 Global Polynucleotides Injectable Sales (2021-2032)
- 2.2.3 Global Polynucleotides Injectable Market Average Price (2021-2032)
- 2.3 Polynucleotides Injectable by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Eyes
- 2.3.3 Lips
- 2.3.4 Forehead
- 2.3.5 Jawline & Cheekbones
- 2.3.6 Others
- 2.4 Polynucleotides Injectable by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 MedSpas
- 2.4.3 Aesthetic & Cosmetic Centers
- 2.4.4 Hospitals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Polynucleotides Injectable Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Polynucleotides Injectable Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Polynucleotides Injectable Revenue of Manufacturers (2021-2026)
- 3.4 Global Polynucleotides Injectable Average Price by Manufacturers (2021-2026)
- 3.5 Global Polynucleotides Injectable Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Polynucleotides Injectable, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Polynucleotides Injectable, Product Type & Application
- 3.8 Global Manufacturers of Polynucleotides Injectable, Established Date
- 3.9 Global Polynucleotides Injectable Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 PharmaResearch Products Co., Ltd.
- 4.1.1 PharmaResearch Products Co., Ltd. Company Information
- 4.1.2 PharmaResearch Products Co., Ltd. Business Overview
- 4.1.3 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product Portfolio
- 4.1.5 PharmaResearch Products Co., Ltd. Recent Developments
- 4.2 Mastelli Srl
- 4.2.1 Mastelli Srl Company Information
- 4.2.2 Mastelli Srl Business Overview
- 4.2.3 Mastelli Srl Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mastelli Srl Polynucleotides Injectable Product Portfolio
- 4.2.5 Mastelli Srl Recent Developments
- 4.3 Promoitalia Group S.p.A.
- 4.3.1 Promoitalia Group S.p.A. Company Information
- 4.3.2 Promoitalia Group S.p.A. Business Overview
- 4.3.3 Promoitalia Group S.p.A. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Promoitalia Group S.p.A. Polynucleotides Injectable Product Portfolio
- 4.3.5 Promoitalia Group S.p.A. Recent Developments
- 4.4 GUNA S.p.A.
- 4.4.1 GUNA S.p.A. Company Information
- 4.4.2 GUNA S.p.A. Business Overview
- 4.4.3 GUNA S.p.A. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GUNA S.p.A. Polynucleotides Injectable Product Portfolio
- 4.4.5 GUNA S.p.A. Recent Developments
- 4.5 Caregen Co., Ltd.
- 4.5.1 Caregen Co., Ltd. Company Information
- 4.5.2 Caregen Co., Ltd. Business Overview
- 4.5.3 Caregen Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Caregen Co., Ltd. Polynucleotides Injectable Product Portfolio
- 4.5.5 Caregen Co., Ltd. Recent Developments
- 4.6 Medytox Inc.
- 4.6.1 Medytox Inc. Company Information
- 4.6.2 Medytox Inc. Business Overview
- 4.6.3 Medytox Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Medytox Inc. Polynucleotides Injectable Product Portfolio
- 4.6.5 Medytox Inc. Recent Developments
- 4.7 Suneva Medical, Inc.
- 4.7.1 Suneva Medical, Inc. Company Information
- 4.7.2 Suneva Medical, Inc. Business Overview
- 4.7.3 Suneva Medical, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Suneva Medical, Inc. Polynucleotides Injectable Product Portfolio
- 4.7.5 Suneva Medical, Inc. Recent Developments
- 4.8 Euroresearch S.r.l.
- 4.8.1 Euroresearch S.r.l. Company Information
- 4.8.2 Euroresearch S.r.l. Business Overview
- 4.8.3 Euroresearch S.r.l. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Euroresearch S.r.l. Polynucleotides Injectable Product Portfolio
- 4.8.5 Euroresearch S.r.l. Recent Developments
- 4.9 Anteis SA (now part of Merz Pharmaceuticals)
- 4.9.1 Anteis SA (now part of Merz Pharmaceuticals) Company Information
- 4.9.2 Anteis SA (now part of Merz Pharmaceuticals) Business Overview
- 4.9.3 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product Portfolio
- 4.9.5 Anteis SA (now part of Merz Pharmaceuticals) Recent Developments
- 4.10 Hyundai Pharm Co., Ltd.
- 4.10.1 Hyundai Pharm Co., Ltd. Company Information
- 4.10.2 Hyundai Pharm Co., Ltd. Business Overview
- 4.10.3 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product Portfolio
- 4.10.5 Hyundai Pharm Co., Ltd. Recent Developments
- 4.11 Regen Biotech, Inc.
- 4.11.1 Regen Biotech, Inc. Company Information
- 4.11.2 Regen Biotech, Inc. Business Overview
- 4.11.3 Regen Biotech, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Regen Biotech, Inc. Polynucleotides Injectable Product Portfolio
- 4.11.5 Regen Biotech, Inc. Recent Developments
- 4.12 Evolus, Inc.
- 4.12.1 Evolus, Inc. Company Information
- 4.12.2 Evolus, Inc. Business Overview
- 4.12.3 Evolus, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Evolus, Inc. Polynucleotides Injectable Product Portfolio
- 4.12.5 Evolus, Inc. Recent Developments
- 4.13 Cleviel
- 4.13.1 Cleviel Company Information
- 4.13.2 Cleviel Business Overview
- 4.13.3 Cleviel Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cleviel Polynucleotides Injectable Product Portfolio
- 4.13.5 Cleviel Recent Developments
- 4.14 Promedica International
- 4.14.1 Promedica International Company Information
- 4.14.2 Promedica International Business Overview
- 4.14.3 Promedica International Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Promedica International Polynucleotides Injectable Product Portfolio
- 4.14.5 Promedica International Recent Developments
- 4.15 NeoGenesis Co., Ltd.
- 4.15.1 NeoGenesis Co., Ltd. Company Information
- 4.15.2 NeoGenesis Co., Ltd. Business Overview
- 4.15.3 NeoGenesis Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 NeoGenesis Co., Ltd. Polynucleotides Injectable Product Portfolio
- 4.15.5 NeoGenesis Co., Ltd. Recent Developments
5 Global Polynucleotides Injectable Market Scenario by Region
- 5.1 Global Polynucleotides Injectable Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Polynucleotides Injectable Sales by Region: 2021-2032
- 5.2.1 Global Polynucleotides Injectable Sales by Region: 2021-2026
- 5.2.2 Global Polynucleotides Injectable Sales by Region: 2027-2032
- 5.3 Global Polynucleotides Injectable Revenue by Region: 2021-2032
- 5.3.1 Global Polynucleotides Injectable Revenue by Region: 2021-2026
- 5.3.2 Global Polynucleotides Injectable Revenue by Region: 2027-2032
- 5.4 North America Polynucleotides Injectable Market Facts & Figures by Country
- 5.4.1 North America Polynucleotides Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Polynucleotides Injectable Sales by Country (2021-2032)
- 5.4.3 North America Polynucleotides Injectable Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Polynucleotides Injectable Market Facts & Figures by Country
- 5.5.1 Europe Polynucleotides Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Polynucleotides Injectable Sales by Country (2021-2032)
- 5.5.3 Europe Polynucleotides Injectable Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Polynucleotides Injectable Market Facts & Figures by Country
- 5.6.1 Asia Pacific Polynucleotides Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Polynucleotides Injectable Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Polynucleotides Injectable Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Polynucleotides Injectable Market Facts & Figures by Country
- 5.7.1 South America Polynucleotides Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Polynucleotides Injectable Sales by Country (2021-2032)
- 5.7.3 South America Polynucleotides Injectable Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Polynucleotides Injectable Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Polynucleotides Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Polynucleotides Injectable Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Polynucleotides Injectable Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Polynucleotides Injectable Sales by Type (2021-2032)
- 6.1.1 Global Polynucleotides Injectable Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Polynucleotides Injectable Sales Market Share by Type (2021-2032)
- 6.2 Global Polynucleotides Injectable Revenue by Type (2021-2032)
- 6.2.1 Global Polynucleotides Injectable Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Polynucleotides Injectable Revenue Market Share by Type (2021-2032)
- 6.3 Global Polynucleotides Injectable Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Polynucleotides Injectable Sales by Application (2021-2032)
- 7.1.1 Global Polynucleotides Injectable Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Polynucleotides Injectable Sales Market Share by Application (2021-2032)
- 7.2 Global Polynucleotides Injectable Revenue by Application (2021-2032)
- 7.2.1 Global Polynucleotides Injectable Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Polynucleotides Injectable Revenue Market Share by Application (2021-2032)
- 7.3 Global Polynucleotides Injectable Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Polynucleotides Injectable Value Chain Analysis
- 8.1.1 Polynucleotides Injectable Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Polynucleotides Injectable Production Mode & Process
- 8.2 Polynucleotides Injectable Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Polynucleotides Injectable Distributors
- 8.2.3 Polynucleotides Injectable Customers
9 Global Polynucleotides Injectable Analyzing Market Dynamics
- 9.1 Polynucleotides Injectable Industry Trends
- 9.2 Polynucleotides Injectable Industry Drivers
- 9.3 Polynucleotides Injectable Industry Opportunities and Challenges
- 9.4 Polynucleotides Injectable Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst